131 related articles for article (PubMed ID: 32917855)
1. Reduction in MLKL-mediated endosomal trafficking enhances the TRAIL-DR4/5 signal to increase cancer cell death.
Park SY; Park HH; Park SY; Hong SM; Yoon S; Morgan MJ; Kim YS
Cell Death Dis; 2020 Sep; 11(9):744. PubMed ID: 32917855
[TBL] [Abstract][Full Text] [Related]
2. MLKL, the Protein that Mediates Necroptosis, Also Regulates Endosomal Trafficking and Extracellular Vesicle Generation.
Yoon S; Kovalenko A; Bogdanov K; Wallach D
Immunity; 2017 Jul; 47(1):51-65.e7. PubMed ID: 28666573
[TBL] [Abstract][Full Text] [Related]
3. Translocation of mixed lineage kinase domain-like protein to plasma membrane leads to necrotic cell death.
Chen X; Li W; Ren J; Huang D; He WT; Song Y; Yang C; Li W; Zheng X; Chen P; Han J
Cell Res; 2014 Jan; 24(1):105-21. PubMed ID: 24366341
[TBL] [Abstract][Full Text] [Related]
4. TRAIL induces apoptosis but not necroptosis in colorectal and pancreatic cancer cells preferentially via the TRAIL-R2/DR5 receptor.
Nahacka Z; Svadlenka J; Peterka M; Ksandrova M; Benesova S; Neuzil J; Andera L
Biochim Biophys Acta Mol Cell Res; 2018 Mar; 1865(3):522-531. PubMed ID: 29278689
[TBL] [Abstract][Full Text] [Related]
5. Death receptor 5 is activated by fucosylation in colon cancer cells.
Zhang B; van Roosmalen IAM; Reis CR; Setroikromo R; Quax WJ
FEBS J; 2019 Feb; 286(3):555-571. PubMed ID: 30589515
[TBL] [Abstract][Full Text] [Related]
6. RIP1 is a central signaling protein in regulation of TNF-α/TRAIL mediated apoptosis and necroptosis during Newcastle disease virus infection.
Liao Y; Wang HX; Mao X; Fang H; Wang H; Li Y; Sun Y; Meng C; Tan L; Song C; Qiu X; Ding C
Oncotarget; 2017 Jun; 8(26):43201-43217. PubMed ID: 28591723
[TBL] [Abstract][Full Text] [Related]
7. Pterostilbene Enhances TRAIL-Induced Apoptosis through the Induction of Death Receptors and Downregulation of Cell Survival Proteins in TRAIL-Resistance Triple Negative Breast Cancer Cells.
Hung CM; Liu LC; Ho CT; Lin YC; Way TD
J Agric Food Chem; 2017 Dec; 65(51):11179-11191. PubMed ID: 29164887
[TBL] [Abstract][Full Text] [Related]
8. Mixed Lineage Kinase Domain-like Protein MLKL Breaks Down Myelin following Nerve Injury.
Ying Z; Pan C; Shao T; Liu L; Li L; Guo D; Zhang S; Yuan T; Cao R; Jiang Z; Chen S; Wang F; Wang X
Mol Cell; 2018 Nov; 72(3):457-468.e5. PubMed ID: 30344099
[TBL] [Abstract][Full Text] [Related]
9. An HPLC method associated with a thermodynamic analysis to compare the binding of TRAIL and its nanovectorized form to death receptors DR4 and DR5 and their relationship to cytotoxicity.
Guillaume YC; Lethier L; André C
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Nov; 1036-1037():142-148. PubMed ID: 27750195
[TBL] [Abstract][Full Text] [Related]
10. Mixed lineage kinase domain-like protein MLKL causes necrotic membrane disruption upon phosphorylation by RIP3.
Wang H; Sun L; Su L; Rizo J; Liu L; Wang LF; Wang FS; Wang X
Mol Cell; 2014 Apr; 54(1):133-146. PubMed ID: 24703947
[TBL] [Abstract][Full Text] [Related]
11. Smac mimetics and type II interferon synergistically induce necroptosis in various cancer cell lines.
Cekay MJ; Roesler S; Frank T; Knuth AK; Eckhardt I; Fulda S
Cancer Lett; 2017 Dec; 410():228-237. PubMed ID: 28923396
[TBL] [Abstract][Full Text] [Related]
12. DR4 specific TRAIL variants are more efficacious than wild-type TRAIL in pancreatic cancer.
Yu R; Albarenque SM; Cool RH; Quax WJ; Mohr A; Zwacka RM
Cancer Biol Ther; 2014; 15(12):1658-66. PubMed ID: 25482930
[TBL] [Abstract][Full Text] [Related]
13. DR4-Ser424
Lee H; Oh Y; Jeon YJ; Lee SY; Kim H; Lee HJ; Jung YK
Cancer Res; 2019 Jun; 79(11):2839-2852. PubMed ID: 30987996
[TBL] [Abstract][Full Text] [Related]
14. Pro-survival effects by NF-κB, Akt and ERK(1/2) and anti-apoptosis actions by Six1 disrupt apoptotic functions of TRAIL-Dr4/5 pathway in ovarian cancer.
Yang J; Li G; Zhang K
Biomed Pharmacother; 2016 Dec; 84():1078-1087. PubMed ID: 27780136
[TBL] [Abstract][Full Text] [Related]
15. TRAIL resistance of breast cancer cells is associated with constitutive endocytosis of death receptors 4 and 5.
Zhang Y; Zhang B
Mol Cancer Res; 2008 Dec; 6(12):1861-71. PubMed ID: 19074831
[TBL] [Abstract][Full Text] [Related]
16. TRAIL death receptor 4 signaling via lysosome fusion and membrane raft clustering in coronary arterial endothelial cells: evidence from ASM knockout mice.
Li X; Han WQ; Boini KM; Xia M; Zhang Y; Li PL
J Mol Med (Berl); 2013 Jan; 91(1):25-36. PubMed ID: 23108456
[TBL] [Abstract][Full Text] [Related]
17. Snake venom toxin from Vipera lebetina turanica sensitizes cancer cells to TRAIL through ROS- and JNK-mediated upregulation of death receptors and downregulation of survival proteins.
Park MH; Jo M; Won D; Song HS; Song MJ; Hong JT
Apoptosis; 2012 Dec; 17(12):1316-26. PubMed ID: 23007278
[TBL] [Abstract][Full Text] [Related]
18. Gefitinib enhances human colon cancer cells to TRAIL-induced apoptosis of via autophagy- and JNK-mediated death receptors upregulation.
Chen L; Meng Y; Guo X; Sheng X; Tai G; Zhang F; Cheng H; Zhou Y
Apoptosis; 2016 Nov; 21(11):1291-1301. PubMed ID: 27629794
[TBL] [Abstract][Full Text] [Related]
19. MLKL-PITPα signaling-mediated necroptosis contributes to cisplatin-triggered cell death in lung cancer A549 cells.
Jing L; Song F; Liu Z; Li J; Wu B; Fu Z; Jiang J; Chen Z
Cancer Lett; 2018 Feb; 414():136-146. PubMed ID: 29104146
[TBL] [Abstract][Full Text] [Related]
20. Smac mimetics and TRAIL cooperate to induce MLKL-dependent necroptosis in Burkitt's lymphoma cell lines.
Koch A; Jeiler B; Roedig J; van Wijk SJL; Dolgikh N; Fulda S
Neoplasia; 2021 May; 23(5):539-550. PubMed ID: 33971465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
